Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2.
Publication
, Journal Article
Huang, L; Yuen, TT-T; Ye, Z; Liu, S; Zhang, G; Chu, H; Yue, J
Published in: Signal transduction and targeted therapy
April 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Signal transduction and targeted therapy
DOI
EISSN
2059-3635
ISSN
2095-9907
Publication Date
April 2021
Volume
6
Issue
1
Start / End Page
168
Related Subject Headings
- SARS-CoV-2
- Protein Transport
- Lysosomes
- Humans
- HEK293 Cells
- Endosomes
- COVID-19 Drug Treatment
- COVID-19
- Benzylisoquinolines
- Angiotensin-Converting Enzyme 2
Citation
APA
Chicago
ICMJE
MLA
NLM
Huang, L., Yuen, T.-T., Ye, Z., Liu, S., Zhang, G., Chu, H., & Yue, J. (2021). Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2. Signal Transduction and Targeted Therapy, 6(1), 168. https://doi.org/10.1038/s41392-021-00584-6
Huang, Lihong, Terrence Tsz-Tai Yuen, Zuodong Ye, Shuyan Liu, Guoliang Zhang, Hin Chu, and Jianbo Yue. “Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2.” Signal Transduction and Targeted Therapy 6, no. 1 (April 2021): 168. https://doi.org/10.1038/s41392-021-00584-6.
Huang L, Yuen TT-T, Ye Z, Liu S, Zhang G, Chu H, et al. Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2. Signal transduction and targeted therapy. 2021 Apr;6(1):168.
Huang, Lihong, et al. “Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2.” Signal Transduction and Targeted Therapy, vol. 6, no. 1, Apr. 2021, p. 168. Epmc, doi:10.1038/s41392-021-00584-6.
Huang L, Yuen TT-T, Ye Z, Liu S, Zhang G, Chu H, Yue J. Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2. Signal transduction and targeted therapy. 2021 Apr;6(1):168.
Published In
Signal transduction and targeted therapy
DOI
EISSN
2059-3635
ISSN
2095-9907
Publication Date
April 2021
Volume
6
Issue
1
Start / End Page
168
Related Subject Headings
- SARS-CoV-2
- Protein Transport
- Lysosomes
- Humans
- HEK293 Cells
- Endosomes
- COVID-19 Drug Treatment
- COVID-19
- Benzylisoquinolines
- Angiotensin-Converting Enzyme 2